RPS6KB1 and melanoma: On two others similar studies, one by Kent et al. (2009) [43] in canine melanoma cell lines and the other in canine osteosarcoma cell lines treated with rapamycin, both resulted in a reduction of phosphorylated mTOR expression and phosphorylated p70S6K expression.